IP Library Granted Patent US 9,719,136
Granted Patent B2
US 9,719,136 · App. 14/566,445 · Granted Aug 1, 2017

Methods for adding adapters to nucleic acids and compositions for practicing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,719,136
App. No.
14/566,445
Granted
Aug 1, 2017
Kind
B2
Abstract

Provided are methods of adding adapters to nucleic acids. The methods include combining in a reaction mixture a template nucleic acid, a template switch oligonucleotide, a polymerase, and dNTPs. The reaction mixture components are combined under conditions sufficient to produce a product nucleic acid that includes the template nucleic acid and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid including a region polymerized from the dNTPs by the polymerase. The methods further include attaching sequencing platform adapter constructs to ends of the product nucleic acid or a derivative thereof. Aspects of the invention further include compositions and kits.

Claims (35)

1. A method comprising:

(a) combining:

a template nucleic acid;

a template switch oligonucleotide comprising a 3′ hybridization domain and one or more ribonucleotides 5′ of the 3′ hybridization domain;

a polymerase; and

dNTPs;

in a reaction mixture under conditions sufficient to produce a first strand cDNA complementary to the template nucleic acid and the template switch oligonucleotide;

b) degrading the template switch oligonucleotide; and

c) amplifying the first strand cDNA.

2. The method according to claim 1 , wherein the template switch oligonucleotide comprises two or more ribonucleotides 5′ of the 3′ hybridization domain.

3. The method according to claim 1 , wherein the template switch oligonucleotide is degraded using a ribonuclease.

4. The method according to claim 1 , wherein the amplifying is performed with a primer comprising a barcode.

5. The method according to claim 1 , wherein said template nucleic acid is from a single cell.

6. The method according to claim 1 , wherein the 3′ hybridization domain comprises a homo-trinucleotide.

7. The method according to claim 1 , wherein the 3′ hybridization domain comprises a hetero-trinucleotide.

8. The method according to claim 1 , wherein the template switch oligonucleotide comprises a sequencing platform nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

9. The method according to claim 1 , wherein the template nucleic acid is sheared or fragmented template nucleic acid.

10. The method according to claim 9 , wherein the method further comprises shearing or fragmenting the template nucleic acid prior to the combining.

11. The method according to claim 1 , wherein the method comprises heating the reaction mixture.

12. The method according to claim 1 , wherein the reaction mixture includes a first strand synthesis primer comprising at least one exo-sample nucleotide.

13. The method according to claim 1 , wherein the degrading comprises degrading dissociated template switch oligonucleotide.

14. A method comprising:

(a) combining:

a template nucleic acid;

a template switch oligonucleotide comprising one or more exo-sample nucleotides selected from the group consisting of: bromodeoxyuridine, 7-methylguanine, 5,6-dihydroxydeoxythymidine, and 3-methyldeoxadenosine, or any combination thereof and a 3′ hybridization domain;

a polymerase; and

dNTPs;

in a reaction mixture under conditions sufficient to produce a first strand cDNA complementary to the template nucleic acid and the template switch oligonucleotide;

b) degrading a portion of the template switch oligonucleotide that is 5′ of the 3′ hybridization domain; and

c) amplifying the first strand cDNA.

15. The method according to claim 14 , wherein the template switch oligonucleotide is degraded using one or more enzymes.

16. The method according to claim 15 , wherein the one or more enzymes are selected from the group consisting of: a uracil-N-glycosylase, a lyase, a DNA glycosylase-lyase and combinations thereof.

17. The method according to claim 16 , wherein the DNA glycosylase-lyase is Endonuclease VIII.

18. The method according to claim 14 , wherein the template switch oligonucleotide further comprises a ribonucleotide 5′ of the 3′ hybridization domain.

19. The method according to claim 14 , wherein the template switch oligonucleotide comprises a sequencing platform nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

Assignments (2)
CHANGE OF NAME Recorded Aug 4, 2016
From: CLONTECH LABORATORIES, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 039584/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2015
From: BETTS, CRAIG; FARMER, ANDREW ALAN
To: CLONTECH LABORATORIES, INC.
Reel/Frame 034942/0495 →